Regulation of mature T lymphocyte proliferation and differentiation by Par-4

被引:41
作者
Lafuente, MJ
Martin, P
Garcia-Cao, I
Diaz-Meco, MT
Serrano, M
Moscat, J [1 ]
机构
[1] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain
[2] Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid 28049, Spain
关键词
atypical PKCs; B lymphocytes; NF-kappa B; Par-4; T lymphocytes;
D O I
10.1093/emboj/cdg460
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The genetic inactivation of the atypical protein kinase C (aPKC) inhibitor, Par-4, gives rise to increased NF-kappaB activation and decreased stimulation of JNK in embryo fibroblasts. Here we have characterized the immunological phenotype of the Par-4(-/-) mice and found that the loss of this gene leads to an increased proliferative response of peripheral T cells when challenged through the TCR. This is accompanied by a higher increase in cell cycle entry and inhibition of apoptosis, with enhanced IL-2 secretion but normal CD25 synthesis. Interestingly, the TCR-triggered activation of NF-kappaB was augmented and that of JNK was severely abrogated. Consistent with previous data from knock outs of different JNKs, NFATc1 activation and IL-4 secretion were augmented in the Par-4-deficient CD4(+) T cells, suggesting that the loss of Par-4 drives T-cell differentiation towards a Th2 response. This is compelling evidence that Par-4 is a novel modulator of the immune response through its ability to impact aPKC activity, which translates into lower JNK signaling.
引用
收藏
页码:4689 / 4698
页数:10
相关论文
共 23 条
[1]   c-Jun NH2-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8+ T cell-mediated antiviral immunity [J].
Arbour, N ;
Naniche, D ;
Homann, D ;
Davis, RJ ;
Flavell, RA ;
Oldstone, MBA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (07) :801-810
[2]   The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression [J].
Barradas, M ;
Monjas, A ;
Diaz-Meco, MT ;
Serrano, M ;
Moscat, J .
EMBO JOURNAL, 1999, 18 (22) :6362-6369
[3]   Expression and function of prostate-apoptosis-response gene-4 in lymphatic cells [J].
Boehrer, S ;
Chow, KU ;
Ruthardt, M ;
Hoelzer, D ;
Mitrou, PS ;
Weidmann, E .
LEUKEMIA & LYMPHOMA, 2002, 43 (09) :1737-1741
[4]  
Chow W., 2000, INT J ENG PERFORMANC, V2, P1
[5]   C-jun NH2-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8+ T cell activation [J].
Conze, D ;
Krahl, T ;
Kennedy, N ;
Weiss, L ;
Lumsden, J ;
Hess, P ;
Flavell, RA ;
Le Gros, G ;
Davis, RJ ;
Rincón, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (07) :811-823
[6]   NFAT signaling: Choreographing the social lives of cells [J].
Crabtree, GR ;
Olson, EN .
CELL, 2002, 109 :S67-S79
[7]   Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling [J].
De Smaele, E ;
Zazzeroni, F ;
Papa, S ;
Nguyen, DU ;
Jin, RG ;
Jones, J ;
Cong, R ;
Franzoso, G .
NATURE, 2001, 414 (6861) :308-313
[8]   Inactivation of the inhibitory κB protein kinase nuclear factor κB pathway by Par-4 expression potentiates tumor necrosis factor α-induced apoptosis [J].
Diaz-Meco, MT ;
Lallena, MJ ;
Monjas, A ;
Frutos, S ;
Moscat, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (28) :19606-19612
[9]   The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C [J].
DiazMeco, MT ;
Municio, MM ;
Frutos, S ;
Sanchez, P ;
Lozano, J ;
Sanz, L ;
Moscat, J .
CELL, 1996, 86 (05) :777-786
[10]   Defective T cell differentiation in the absence of Jnk1 [J].
Dong, C ;
Yang, DD ;
Wysk, M ;
Whitmarsh, AJ ;
Davis, RJ ;
Flavell, RA .
SCIENCE, 1998, 282 (5396) :2092-2095